Lumexa Imaging (NASDAQ:LMRI) Shares Gap Up – Should You Buy?

Shares of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRIGet Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $6.77, but opened at $7.25. Lumexa Imaging shares last traded at $7.2710, with a volume of 465,230 shares.

Wall Street Analyst Weigh In

Several research analysts have weighed in on LMRI shares. Barclays dropped their price target on Lumexa Imaging from $23.00 to $15.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Raymond James Financial upgraded Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price target for the company in a research note on Monday, February 9th. Finally, Weiss Ratings started coverage on Lumexa Imaging in a research note on Wednesday, May 13th. They issued a “sell (e-)” rating for the company. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $19.00.

Get Our Latest Research Report on LMRI

Lumexa Imaging Stock Up 6.2%

The firm’s 50-day moving average is $10.18.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Assetmark Inc. bought a new position in shares of Lumexa Imaging during the 4th quarter valued at approximately $36,000. Strs Ohio bought a new position in shares of Lumexa Imaging during the 1st quarter valued at approximately $38,000. Barclays PLC bought a new position in shares of Lumexa Imaging during the 4th quarter valued at approximately $133,000. PNC Financial Services Group Inc. bought a new position in shares of Lumexa Imaging during the 1st quarter valued at approximately $63,000. Finally, Sandia Investment Management LP bought a new position in shares of Lumexa Imaging during the 4th quarter valued at approximately $185,000.

About Lumexa Imaging

(Get Free Report)

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).

Read More

Receive News & Ratings for Lumexa Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumexa Imaging and related companies with MarketBeat.com's FREE daily email newsletter.